Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Internal validation & live display
Insurers and partners see a safer profile
Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Society of ActuariesCAS
Proud contributor to the Society of Actuaries.
Company Logo
ChemoMetec
Boost Score +25 with badge (5 left)
748
/1000
Moderate
Verified Badge
Boost Arrows
773
/1000
Fair
ChemoMetec

ChemoMetec Vendor Cyber Rating & Cyber Score

chemometec.com

ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment. We specialize in developing and producing high-precision instrumentation, delivering consistent data for thousands of customers across biotech, pharma and academic segments. We are experiencing exponential growth, as the company strives towards our goal to be the number one provider in Life Sciences. Designed, manufactured and tested in Denmark, our instruments and consumables are built with quality materials and dedicated expert workmanship. Find us on Glassdoor: https://bit.ly/3pjjzTA


ChemoMetec A.I CyberSecurity Scoring

Scoring History
ChemoMetec
Company Information
Website:https://chemometec.com
Employees number:194
Number of followers:10,908
NAICS:33325
Industry Type:Automation Machinery Manufacturing
Homepage:chemometec.com
ChemoMetec Risk Score (AI oriented)
Between 700 and 749
logo
ChemoMetecAutomation Machinery Manufacturing
Updated:
25/02/2026
748/1000
Moderate
Ba
AaaAaABaaBaBCaaCaC
Powered by our proprietary A.I cyber incident model
Insurance prefers TPRM score to calculate premium
ChemoMetec Global Score (TPRM)
xxxx
logo
ChemoMetecAutomation Machinery Manufacturing
•••
Score locked
Instant access to detailed risk factors
Vulnerabilities
Benchmark vs. industry & size peers
Findings
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…